- Home
- CCU vs ZLAB Comparison
CCU vs ZLAB Comparison
Compare CCU & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCU | ZLAB |
|---|---|---|
| Founded | 1850 | 2013 |
| Country | Chile | China |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2001 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CCU | ZLAB |
|---|---|---|
| Price | $11.19 | $17.14 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $12.00 | ★ $49.60 |
| AVG Volume (30 Days) | 159.7K | ★ 814.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $7.42 | $9.75 |
| Revenue Next Year | $4.71 | $26.03 |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $10.71 | $15.96 |
| 52 Week High | $15.36 | $44.34 |
Technical Indicators
Market Signals| Indicator | CCU | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 33.89 |
| Support Level | $10.81 | $17.11 |
| Resistance Level | $12.37 | $19.64 |
| Average True Range (ATR) | 0.39 | 0.68 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 5.85 | 16.20 |
Price Performance
Historical ComparisonAbout CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.